[CAS NO. 132-98-9]  Penicillin V Potassium

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [132-98-9]

Catalog
HY-B0975
Brand
MCE
CAS
132-98-9

DESCRIPTION [132-98-9]

Overview

MDLMFCD00051771
Molecular Weight388.48
Molecular FormulaC16H17KN2O5S
SMILESO=C(O[K])[C@@H](C(C)(C)S[C@]1([H])[C@@H]2NC(COC3=CC=CC=C3)=O)N1C2=O

For research use only. We do not sell to patients.

Summary

Penicillin V Potassium (Phenoxymethylpenicillin potassium salt) is an orally active antibiotic . Penicillin V Potassium inhibits the growth of Streptococci , C. difficile and S. aureus . Penicillin V Potassium can be used for the research of otitis, sinusitis, pharyngitis and tonsillitis [1] [2] [3] [4] .


In Vitro

Penicillin V (0.002-8.0 mg/L) inhibits the growth of Streptococci , with the minimum inhibitory concentrations (MICs) of 0.004-0.008 mg/L [2] .
Penicillin V (0.002-8.0 mg/L) inhibits the growth of C. difficile , with a MIC 90 of 8 mg/L [3] .
Penicillin V (0.004-0.063 mg/L; 18 h) inhibits the growth of Staphylococcus aureus , with a MIC of 0.016 mg/L [4] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.


In Vivo

Penicillin V (0.063-0.25 mg/kg; a single s.c.) inhibits the outgrowth of S. aureus in mice thigh muscle [4] .
Penicillin V (100 mg/kg; p.o. once daily for 5 d) avoids the fulminant infection of acute purulent otitis media (AOM) in rats [5] .
Penicillin V (2 mg/kg; a single s.c.) exhibits the plasma half-life (61 min) and mean AUC (0.47 mg/L•h) [4] [4] .

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Specific pathogen free (SPF) male Swiss mice (20-25 g) are inoculated S. aureus [4]
Dosage: 0.063, 0.13, 0.25 mg/kg
Administration: A single s.c.
Result: Decreased the number of CFU (1.34×10 7 counts/mL) compared to controls (3.5×10 7 counts/mL) at the dose of 0.25 mg/kg.

Clinical Trial

NCT Number Sponsor Condition Start Date Phase
NCT01499875 University of Aarhus|Aarhus University Hospital Skejby|Department of Microbiological Surveillance and Research, SSI.
Phenoxymethylpenicillin
January 2012 Phase 1
NCT02922686 Royal College of Surgeons, Ireland|Health Research Board, Ireland
Cellulitis|Wound Infection|Abscess
December 2016 Phase 4
NCT02185209 Margareta Hultin|Karolinska Institutet
Periodontal Diseases|Periimplantitis
March 2015 Phase 4

Appearance

Solid


Source

strains of Penicillium chrysogenum


Shipping

Room temperature in continental US; may vary elsewhere.


Storage

4°C, sealed storage, away from moisture

* In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)


Solvent & Solubility

In Vitro:

DMSO : 12 mg/mL ( 30.89 mM ; Need ultrasonic)

H 2 O : 6 mg/mL ( 15.44 mM ; Need ultrasonic and warming)

Preparing
Stock Solutions
Concentration Solvent Mass 1 mg 5 mg 10 mg
1 mM 2.5741 mL 12.8707 mL 25.7414 mL
5 mM 0.5148 mL 2.5741 mL 5.1483 mL
10 mM 0.2574 mL 1.2871 mL 2.5741 mL
* Please refer to the solubility information to select the appropriate solvent.
In Vivo:
  • 1.

    Add each solvent one by one: PBS

    Solubility: 100 mg/mL (257.41 mM); Clear solution; Need ultrasonic

  • 2.

    Add each solvent one by one: 10% DMSO >> 40% PEG300 >> 5% Tween-80 >> 45% saline

    Solubility: ≥ 1.2 mg/mL (3.09 mM); Clear solution

  • 3.

    Add each solvent one by one: 10% DMSO >> 90% (20% SBE-β-CD in saline)

    Solubility: ≥ 1.2 mg/mL (3.09 mM); Clear solution

  • 4.

    Add each solvent one by one: 10% DMSO >> 90% corn oil

    Solubility: ≥ 1.2 mg/mL (3.09 mM); Clear solution

* All of the co-solvents are available by MCE.


Synonyms

4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenoxyacetyl)amino]-, potassium salt (1:1), (2S,5R,6R)-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-(2-phenoxyacetamido)-, monopotassium salt
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-, monopotassium salt, [2S-(2α,5α,6β)]-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(phenoxyacetyl)amino]-, monopotassium salt, (2S,5R,6R)-
V-Cillin K
Compocillin VK
Penicillin V potassium
Pen-Vee-K
Pen-Vee K Powder
Penvikal
Phenoxymethylpenicillin potassium
Potassium penicillin V
Potassium penicillin V salt
Potassium phenoxymethylpenicillin
Isocillin
Penicillin V potassium salt
Stabillin VK syrup 62.5
Stabillin VK syrup 125
Phenoxymethylpenicillin potassium salt
Potassium 2,2-dimethyl-6β-phenoxyacetamidopenam-3α-carboxylate
Potassium phenoxymethylpenicillinate
Cliacil
Beromycin
Beromycin (penicillin)
Roscopenin
Fenoxypen
Kavepenin
Penicillin VK
Primcillin
Megacillin-oral
Fenocin
V-Pen
Uticillin Vk
Suspen
Anapenil
Penadur VK Mega
Fenoxcillin
Apsin VK
V-Penicillin Kalium
Newcillin
Trepopen VK
Pen-Vi-K
Milcopen
Robicillin VK
Abbocillin VK
Megacilina Oral
Apo-Pen VK
DuraPenicillin
Pfizerpen Vk
Pentabs
Novopen VK
Beepen Vk
Acipen
Rafapen V-K
Stabilin V-K
Orvek
Penivoral
Betapen Vk
Len VK
Cilicaine VK
Nadopen V
Vepicombin
Trepopen
V-Kal K
V-Cil K
Penoxilin
Pen-V
Distaquaine V-K
Oracillin VK
Ospen KV
Servipen V
Pentacillin
Veetids
L.P.V.
Pentranex
Ispenoral
Arcasin
Novo VK
Ospen 250
Vamosyn
Microcillin VK
Micropen VK
Cilacil
Penvisil
Beapen
Asillin
Rocilin
P.V.O.
PVK
Fenospen
Ledercillin Vk
Monocillin E
Betapen V
Vepen
Ocillin VK
Beromycin 400
Calciopen K
Distakaps V-K
Ospeneff
Pedipen
Dowpen V-K
SK-Penicillin VK
Pen V-K
Antibiocin
Fenocin Forte
Pencompren
Qidpen VK
Orapen
DQV-K
Rocillin VK
Oracil VK
Penapar VK
Icipen
Penagen
Sumapen VK
Arcacil
Penicillin V Potassium